Search Within

Heiko Schoder

  1. "Lymphoma"
Formats
  1. Journal Article (63)
  2. Meeting Abstract (61)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (128)
  2. Department of Medicine (128)
  3. Hematologic Malignancies, Division of (128)
  4. Lymphoma (128)
  5. Molecular Imaging and Therapy Service (128)
  6. Radiology, Department of (128)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (15)
  4. 2022 (7)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (14)
  3. Hematological Oncology (10)
  4. Blood Advances (6)
  5. Leukemia and Lymphoma (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (14)
  3. Wiley Blackwell (12)
  4. Nature Publishing Group (6)
  5. Taylor & Francis Group (5)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (128)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
    Journal Article

    Noy, A.; Schoder, H.; Gonen, M.; Weissler, M.; Ertelt, K.; Cohler, C.; Portlock, C.; Hamlin, P.; Yeung, H. W. D.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Cdk4/6 inhibitor PD 0332991 demonstrates cell cycle inhibition via FLT-PET imaging and tissue analysis in patients with recurrent mantle cell lymphoma
    Meeting Abstract

    Leonard, J. P.; LaCasce, A.; Smith, M. R.; Noy, A.; Yap, J. T.; Van Den Abbeele, A. D.; Yu, J. Q.; Chen-Kiang, S.; Ely, S. A.; Vallabhajosula, S.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Validation of the international harmonization project (IHP) guidelines in early stage Hodgkin lymphoma (HL) treated with adriamycin, vinblastine and gemcitabine (AVG) (CALGB 50203): Early results
    Meeting Abstract

    Kostakoglu, L.; Straus, D. J.; Schoder, H.; LaCasce, A. S.; Bartlett, N. L.; Hall, N.; Johnson, J. L.; Jung, S. H.; Canellos, G. P.; Schwartz, L. H.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Majority of transformed lymphomas have high SUVs on PET scanning similar to diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Noy, A.; Weissler, M.; Schoder, H.; Gonen, M.; Yeung, H.
    Blood (2007)

    Fulltext@MSK | Save
  • Majority of transformed lymphomas have high SUVs on PET scanning similar to diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Weissler, M.; Noy, A.; Schoder, H.; Gonen, M.; Yeung, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
    Journal Article

    Schoder, H.; Noy, A.; Gonen, M.; Weng, L.; Green, D.; Erdi, Y. E.; Larson, S. M.; Yeung, H. W. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Head to head comparison of Gallium-67 imaging and FDG PET in lymphoma patients
    Meeting Abstract

    Schoder, H.; Noy, A.; Gonen, M.; Young, K. S.; Larson, S. M.; Yeung, H. W.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save